Oramed Pharmaceuticals Inc (ORMP)
2.20
-0.14
(-5.98%)
USD |
NASDAQ |
May 28, 16:00
2.20
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals Research and Development Expense (Quarterly): 1.179M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.179M |
December 31, 2023 | 1.766M |
September 30, 2023 | 0.957M |
June 30, 2023 | 1.821M |
March 31, 2023 | 4.427M |
December 31, 2022 | 7.277M |
September 30, 2022 | 5.347M |
June 30, 2022 | 9.179M |
March 31, 2022 | 5.836M |
November 30, 2021 | 6.41M |
August 31, 2021 | 5.844M |
May 31, 2021 | 5.502M |
February 28, 2021 | 3.869M |
November 30, 2020 | 5.774M |
August 31, 2020 | 2.968M |
May 31, 2020 | 1.925M |
February 29, 2020 | 3.32M |
November 30, 2019 | 2.022M |
August 31, 2019 | 2.20M |
May 31, 2019 | 3.861M |
February 28, 2019 | 3.114M |
November 30, 2018 | 4.347M |
August 31, 2018 | 2.734M |
May 31, 2018 | 4.194M |
February 28, 2018 | 2.724M |
Date | Value |
---|---|
November 30, 2017 | 2.327M |
August 31, 2017 | 2.536M |
May 31, 2017 | 2.267M |
February 28, 2017 | 3.125M |
November 30, 2016 | 2.353M |
August 31, 2016 | 2.795M |
May 31, 2016 | 1.71M |
February 29, 2016 | 1.303M |
November 30, 2015 | 1.901M |
August 31, 2015 | 1.428M |
May 31, 2015 | 0.915M |
February 28, 2015 | 1.136M |
November 30, 2014 | 1.302M |
August 31, 2014 | 0.764M |
May 31, 2014 | 1.089M |
February 28, 2014 | 0.674M |
November 30, 2013 | 0.75M |
August 31, 2013 | 0.2947M |
May 31, 2013 | 0.8356M |
February 28, 2013 | 0.749M |
November 30, 2012 | 0.3926M |
August 31, 2012 | 0.5366M |
May 31, 2012 | 0.2498M |
February 29, 2012 | 0.7106M |
November 30, 2011 | 0.184M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.957M
Minimum
Sep 2023
9.179M
Maximum
Jun 2022
4.074M
Average
3.865M
Median
Research and Development Expense (Quarterly) Benchmarks
ACADIA Pharmaceuticals Inc | 59.68M |
Cassava Sciences Inc | 16.23M |
Vertex Pharmaceuticals Inc | 789.10M |
Cormedix Inc | 0.8374M |
Oragenics Inc | 0.6634M |